• Trade
  • Markets
  • Copy
  • Contests
  • News
  • 24/7
  • Calendar
  • Q&A
  • Chats
Trending
Screeners
SYMBOL
LAST
BID
ASK
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6831.72
6831.72
6831.72
6878.28
6827.18
-38.68
-0.56%
--
DJI
Dow Jones Industrial Average
47654.34
47654.34
47654.34
47971.51
47611.93
-300.64
-0.63%
--
IXIC
NASDAQ Composite Index
23469.19
23469.19
23469.19
23698.93
23455.05
-108.93
-0.46%
--
USDX
US Dollar Index
99.020
99.100
99.020
99.160
98.730
+0.070
+ 0.07%
--
EURUSD
Euro / US Dollar
1.16378
1.16386
1.16378
1.16717
1.16162
-0.00048
-0.04%
--
GBPUSD
Pound Sterling / US Dollar
1.33245
1.33256
1.33245
1.33462
1.33053
-0.00067
-0.05%
--
XAUUSD
Gold / US Dollar
4185.70
4186.04
4185.70
4218.85
4175.92
-12.21
-0.29%
--
WTI
Light Sweet Crude Oil
58.546
58.576
58.546
60.084
58.495
-1.263
-2.11%
--

Community Accounts

Signal Accounts
--
Profit Accounts
--
Loss Accounts
--
View More

Become a signal provider

Sell trading signals to earn additional income

View More

Guide to Copy Trading

Get started with ease and confidence

View More

Signal Accounts for Members

All Signal Accounts

Best Return
  • Best Return
  • Best P/L
  • Best MDD
Past 1W
  • Past 1W
  • Past 1M
  • Past 1Y

All Contests

  • All
  • Trump Updates
  • Recommend
  • Stocks
  • Cryptocurrencies
  • Central Banks
  • Featured News
Top News Only
Share

U.S. Senate Democratic Member And Antitrust Activist Warren Stated That Paramount Skydance's Hostile Takeover Offer Triggered A "Level 5 Antitrust Alert."

Share

Benin Government: Coup Plotters Kidnapped Two Senior Military Officials Who Were Later Freed

Share

Canada: G7 Finance Ministers Discussed Export Controls And Critical Minerals In Call

Share

Benin Government: Nigeria Carried Out Air Strikes To Help Thwart Coup Bid

Share

Fitch: Expects General Government (Gg) Deficit To Fall Modestly In Canada And But Rise Modestly In USA In 2026

Share

An Important Point Of Consensus Was Concern Regarding Application Of Non-Market Policies, Including Export Controls, To Critical Minerals Supply Chains

Share

Fitch: Despite Full-Year Impact Of Tariffs, We Expect USA Fiscal Deficit To Widen In 2026 Due To Additional Tax Cuts Under One Big Beautiful Bill Act

Share

Private Equity Firm Cinven Has Signed A £190 Million Deal To Acquire A Majority Stake In UK Advisory Firm Flint Global

Share

Bank Of England's Taylor Expects Inflation To Fall To Target 'In The Near Term'

Share

Ukraine President Zelenskiy: He Will Travel To Italy On Tuesday

Share

China Is Not Interested In Forcing Russia To End Its War In Ukraine

Share

ICE Certified Arabica Stocks Decreased By 5144 As Of December 08, 2025

Share

UK Government: Leaders All Agreed That "Now Is A Critical Moment And That We Must Continue To Ramp Up Support To Ukraine And Economic Pressure On Putin"

Share

UK Government: After Meeting With The Leaders Of France, Germany And Ukraine, UK Prime Minister Convened A Call With Other European Allies To Update Them On The Latest Situation

Share

Am Best: US Incurred Asbestos Losses Rise Again In 2024 To $1.5 Billion

Share

Readout Of UK Prime Minister's Engagements With Counterparts From France, Germany And European Partners: Discussed Positive Progress Made To Use Immobilised Russian Sovereign Assets To Support Ukraine's Reconstruction

Share

New York Fed Accepts $1.703 Billion Of $1.703 Billion Submitted To Reverse Repo Facility On Dec 08

Share

Ukraine President Zelenskiy: Coalition Of Willing Meeting To Take Place This Week

Share

Ukraine President Zelenskiy: Ukraine Lacks $800 Million For USA Weapons Purchase Programme This Year

Share

Zimbabwe's President Removes Winston Chitando As Mines Minister, Replaces Him With Polite Kambamura

TIME
ACT
FCST
PREV
France Trade Balance (SA) (Oct)

A:--

F: --

P: --
Euro Zone Employment YoY (SA) (Q3)

A:--

F: --

P: --
Canada Part-Time Employment (SA) (Nov)

A:--

F: --

P: --

Canada Unemployment Rate (SA) (Nov)

A:--

F: --

P: --

Canada Full-time Employment (SA) (Nov)

A:--

F: --

P: --

Canada Labor Force Participation Rate (SA) (Nov)

A:--

F: --

P: --

Canada Employment (SA) (Nov)

A:--

F: --

P: --

U.S. PCE Price Index MoM (Sept)

A:--

F: --

P: --

U.S. Personal Income MoM (Sept)

A:--

F: --

P: --

U.S. Core PCE Price Index MoM (Sept)

A:--

F: --

P: --

U.S. PCE Price Index YoY (SA) (Sept)

A:--

F: --

P: --

U.S. Core PCE Price Index YoY (Sept)

A:--

F: --

P: --

U.S. Personal Outlays MoM (SA) (Sept)

A:--

F: --

P: --
U.S. 5-10 Year-Ahead Inflation Expectations (Dec)

A:--

F: --

P: --

U.S. Real Personal Consumption Expenditures MoM (Sept)

A:--

F: --

P: --
U.S. Weekly Total Rig Count

A:--

F: --

P: --

U.S. Weekly Total Oil Rig Count

A:--

F: --

P: --

U.S. Consumer Credit (SA) (Oct)

A:--

F: --

P: --
China, Mainland Foreign Exchange Reserves (Nov)

A:--

F: --

P: --

Japan Trade Balance (Oct)

A:--

F: --

P: --

Japan Nominal GDP Revised QoQ (Q3)

A:--

F: --

P: --

China, Mainland Imports YoY (CNH) (Nov)

A:--

F: --

P: --

China, Mainland Exports (Nov)

A:--

F: --

P: --

China, Mainland Imports (CNH) (Nov)

A:--

F: --

P: --

China, Mainland Trade Balance (CNH) (Nov)

A:--

F: --

P: --

China, Mainland Exports YoY (USD) (Nov)

A:--

F: --

P: --

China, Mainland Imports YoY (USD) (Nov)

A:--

F: --

P: --

Germany Industrial Output MoM (SA) (Oct)

A:--

F: --

P: --
Euro Zone Sentix Investor Confidence Index (Dec)

A:--

F: --

P: --

Canada National Economic Confidence Index

A:--

F: --

P: --

U.K. BRC Like-For-Like Retail Sales YoY (Nov)

--

F: --

P: --

U.K. BRC Overall Retail Sales YoY (Nov)

--

F: --

P: --

Australia Overnight (Borrowing) Key Rate

--

F: --

P: --

RBA Rate Statement
RBA Press Conference
Germany Exports MoM (SA) (Oct)

--

F: --

P: --

U.S. NFIB Small Business Optimism Index (SA) (Nov)

--

F: --

P: --

Mexico 12-Month Inflation (CPI) (Nov)

--

F: --

P: --

Mexico Core CPI YoY (Nov)

--

F: --

P: --

Mexico PPI YoY (Nov)

--

F: --

P: --

U.S. Weekly Redbook Index YoY

--

F: --

P: --

U.S. JOLTS Job Openings (SA) (Oct)

--

F: --

P: --

China, Mainland M1 Money Supply YoY (Nov)

--

F: --

P: --

China, Mainland M0 Money Supply YoY (Nov)

--

F: --

P: --

China, Mainland M2 Money Supply YoY (Nov)

--

F: --

P: --

U.S. EIA Short-Term Crude Production Forecast For The Year (Dec)

--

F: --

P: --

U.S. EIA Natural Gas Production Forecast For The Next Year (Dec)

--

F: --

P: --

U.S. EIA Short-Term Crude Production Forecast For The Next Year (Dec)

--

F: --

P: --

EIA Monthly Short-Term Energy Outlook
U.S. API Weekly Gasoline Stocks

--

F: --

P: --

U.S. API Weekly Cushing Crude Oil Stocks

--

F: --

P: --

U.S. API Weekly Crude Oil Stocks

--

F: --

P: --

U.S. API Weekly Refined Oil Stocks

--

F: --

P: --

South Korea Unemployment Rate (SA) (Nov)

--

F: --

P: --

Japan Reuters Tankan Non-Manufacturers Index (Dec)

--

F: --

P: --

Japan Reuters Tankan Manufacturers Index (Dec)

--

F: --

P: --

Japan Domestic Enterprise Commodity Price Index MoM (Nov)

--

F: --

P: --

Japan Domestic Enterprise Commodity Price Index YoY (Nov)

--

F: --

P: --

China, Mainland PPI YoY (Nov)

--

F: --

P: --

China, Mainland CPI MoM (Nov)

--

F: --

P: --

Italy Industrial Output YoY (SA) (Oct)

--

F: --

P: --

Q&A with Experts
    • All
    • Chatrooms
    • Groups
    • Friends
    Connecting
    .
    .
    .
    Type here...
    Add Symbol or Code

      No matching data

      All
      Trump Updates
      Recommend
      Stocks
      Cryptocurrencies
      Central Banks
      Featured News
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      Search
      Products

      Charts Free Forever

      Chats Q&A with Experts
      Screeners Economic Calendar Data Tools
      Membership Features
      Data Warehouse Market Trends Institutional Data Policy Rates Macro

      Market Trends

      Market Sentiment Order Book Forex Correlations

      Top Indicators

      Charts Free Forever
      Markets

      News

      News Analysis 24/7 Columns Education
      From Institutions From Analysts
      Topics Columnists

      Latest Views

      Latest Views

      Trending Topics

      Top Columnists

      Latest Update

      Signals

      Copy Rankings Latest Signals Become a signal provider AI Rating
      Contests
      Brokers

      Overview Brokers Assessment Rankings Regulators News Claims
      Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
      Q&A Complaint Scam Alert Videos Tips to Detect Scam
      More

      Business
      Events
      Careers About Us Advertising Help Center

      White Label

      Data API

      Web Plug-ins

      Affiliate Program

      Awards Institution Evaluation IB Seminar Salon Event Exhibition
      Vietnam Thailand Singapore Dubai
      Fans Party Investment Sharing Session
      FastBull Summit BrokersView Expo
      Recent Searches
        Top Searches
          Markets
          News
          Analysis
          User
          24/7
          Economic Calendar
          Education
          Data
          • Names
          • Latest
          • Prev

          View All

          No data

          Scan to Download

          Faster Charts, Chat Faster!

          Download App
          English
          • English
          • Español
          • العربية
          • Bahasa Indonesia
          • Bahasa Melayu
          • Tiếng Việt
          • ภาษาไทย
          • Français
          • Italiano
          • Türkçe
          • Русский язык
          • 简中
          • 繁中
          Open Account
          Search
          Products
          Charts Free Forever
          Markets
          News
          Signals

          Copy Rankings Latest Signals Become a signal provider AI Rating
          Contests
          Brokers

          Overview Brokers Assessment Rankings Regulators News Claims
          Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
          Q&A Complaint Scam Alert Videos Tips to Detect Scam
          More

          Business
          Events
          Careers About Us Advertising Help Center

          White Label

          Data API

          Web Plug-ins

          Affiliate Program

          Awards Institution Evaluation IB Seminar Salon Event Exhibition
          Vietnam Thailand Singapore Dubai
          Fans Party Investment Sharing Session
          FastBull Summit BrokersView Expo

          Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

          Acceswire
          BioVie
          -1.90%
          B
          BioVie Inc. Warrant
          0.00%
          Nexalin Technology
          +1.86%
          Nexalin Technology, Inc. Warrant
          0.00%

          ORLANDO, FLORIDA / ACCESS Newswire / October 17, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. and BioVie, Inc. on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, October 18, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

          Access the interviews in their entirety at:

          • NXL: https://www.redchip.com/assets/access/nxl_access

          • BIVI: https://www.redchip.com/assets/access/bivi_access

          In an exclusive interview, Mark White, Chief Executive Officer of Nexalin, will appear on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss Nexalin's game-changing approach to mental healthcare through its proprietary, non-invasive Deep Intracranial Frequency Stimulation (DIFS™) technology. White details the company's growing body of clinical evidence, including collaborations with leading institutions like UC San Diego, and shares updates on the Gen-3 HALO™ Clarity headset and Virtual Clinic model, designed for scalable, at-home treatment. With regulatory approvals secured internationally and U.S. expansion underway, Nexalin is positioned at the forefront of a $537 billion mental health market.

          Cuong Do, President and CEO of BioVie, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss bezisterim (NE3107), BioVie's first-in-class, orally available small molecule that targets inflammation and insulin resistance, two key drivers of Alzheimer's, Parkinson's, and Long COVID, where it has shown encouraging signals of improved cognition, motor function, and reduced neuroinflammation across clinical studies. He will also outline progress with BIV201, BioVie's late-stage orphan drug candidate for refractory ascites, a life-threatening complication of liver cirrhosis with no FDA-approved therapies. With multiple late-stage clinical programs advancing, strong safety data, and multi-billion-dollar market opportunities, BioVie is positioned to deliver significant value creation as it approaches pivotal milestones and potential partnerships.

          NXL and BIVI are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.

          About Nexalin Technology, Inc.

          Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin's products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman. Additional information about the Company is available at: https://nexalin.com/.

          About BioVie, Inc.

          BioVie Inc. is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Alzheimer's disease, Parkinson's disease and long COVID) and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-κB, and the associated neuroinflammation and insulin resistance but not ERK and NFκB homeostatic functions (e.g., insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of AD and PD. Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of long COVID. In liver disease, the Company's Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated and discussed with guidance received from the FDA regarding the design of Phase 3 clinical testing of BIV201 for the reduction of further decompensation in participants with liver cirrhosis and ascites. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis. For more information, visit www.bioviepharma.com.

          About RedChip Companies

          RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. Founded in 1992 as a small-cap research firm, RedChip gained early recognition for initiating coverage on emerging blue chip companies such as Apple, Starbucks, Daktronics, Winnebago, and Nike. Over the past 33 years, RedChip has evolved into a full-service investor relations and media firm, delivering concrete, measurable results for its clients, which have included U.S. Steel, Perfumania, and Celsius Holdings, among others. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

          To learn more about RedChip's products and services, please visit:

          https://www.redchip.com/corporate/investor_relations

          "Discovering Tomorrow's Blue Chips Today"™

          Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

          Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

          Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

          Follow RedChip on Twitter: https://twitter.com/RedChip

          Follow RedChip on YouTube: https://www.youtube.com/@redchip

          Follow RedChip on Rumble: https://rumble.com/c/c-3068340

          Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

          Contact:

          Dave Gentry

          RedChip Companies Inc.

          1-407-644-4256

          info@redchip.com

          --END--

          SOURCE: RedChip Companies, Inc.

          View the original press release on ACCESS Newswire

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Nexalin Technology Inc - Enters Amendment No. 2 To Equity Distribution Agreement - Sec Filing

          Reuters
          Nexalin Technology
          +1.86%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Dj Nexalin Technology Expands Scientific Advisory Board With Appointment Of Dr. Robert Rothstein To Support Alzheimer's And Traumatic Brain Injury Programs

          Reuters
          Nexalin Technology
          +1.86%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Press Release: Nexalin Technology Expands Scientific Advisory Board With Appointment Of Dr. Robert Rothstein To Support Alzheimer's And Traumatic Brain Injury Programs

          Reuters
          Nexalin Technology
          +1.86%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Nexalin Technology Expands Scientific Advisory Board With Appointment Of Dr. Robert Rothstein To Support Alzheimer's And Traumatic Brain Injury Programs

          Reuters
          Nexalin Technology
          +1.86%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.00%

          Investing.com
          Caterpillar
          -1.59%
          Meta Platforms
          -1.07%
          Nexalin Technology
          +1.86%
          Warner Bros Discovery
          +3.16%
          Cisco
          +0.97%

          Investing.com – U.S. stocks were mixed after the close on Wednesday, as gains in the Technology, Industrials and Utilities sectors led shares higher while losses in the Financials, Oil & Gas and Telecoms sectors led shares lower.

          At the close in NYSE, the Dow Jones Industrial Average fell 0.00%, while the S&P 500 index added 0.58%, and the NASDAQ Composite index added 1.12%.

          The best performers of the session on the Dow Jones Industrial Average were Caterpillar Inc (NYSE:CAT), which rose 3.17% or 15.41 points to trade at 502.12 at the close. Meanwhile, NVIDIA Corporation (NASDAQ:NVDA) added 2.18% or 4.04 points to end at 189.08 and Cisco Systems Inc (NASDAQ:CSCO) was up 1.94% or 1.34 points to 70.32 in late trade.

          The worst performers of the session were Goldman Sachs Group Inc (NYSE:GS), which fell 1.66% or 13.14 points to trade at 776.51 at the close. International Business Machines (NYSE:IBM) declined 1.50% or 4.41 points to end at 289.46 and Merck & Company Inc (NYSE:MRK) was down 1.34% or 1.17 points to 86.44.

          The top performers on the S&P 500 were Advanced Micro Devices Inc (NASDAQ:AMD) which rose 11.34% to 235.49, Dell Technologies Inc (NYSE:DELL) which was up 9.04% to settle at 164.51 and Arista Networks (NYSE:ANET) which gained 8.31% to close at 157.36.

          The worst performers were Fair Isaac Corporation (NYSE:FICO) which was down 9.82% to 1,695.01 in late trade, Caesars Entertainment Corporation (NASDAQ:CZR) which lost 5.16% to settle at 23.38 and Warner Bros Discovery Inc (NASDAQ:WBD) which was down 3.82% to 17.89 at the close.

          The top performers on the NASDAQ Composite were Xenetic Biosciences Inc (NASDAQ:XBIO) which rose 146.08% to 10.36, AlphaTON Capital Corp (NASDAQ:ATON) which was up 98.91% to settle at 10.94 and Nexalin Technology Inc (NASDAQ:NXL) which gained 98.25% to close at 1.86.

          The worst performers were Cenntro Electric Group Ltd (NASDAQ:CENN) which was down 56.80% to 0.27 in late trade, Zeta Network Group (NASDAQ:ZNB) which lost 44.12% to settle at 1.90 and Envoy Medical Inc (NASDAQ:COCH) which was down 41.50% to 0.93 at the close.

          Rising stocks outnumbered declining ones on the New York Stock Exchange by 1674 to 1078 and 96 ended unchanged; on the Nasdaq Stock Exchange, 2078 rose and 1272 declined, while 149 ended unchanged.

          Shares in Advanced Micro Devices Inc (NASDAQ:AMD) rose to all time highs; rising 11.34% or 23.98 to 235.49. Shares in Dell Technologies Inc (NYSE:DELL) rose to 52-week highs; gaining 9.04% or 13.64 to 164.51. Shares in Arista Networks (NYSE:ANET) rose to all time highs; rising 8.31% or 12.07 to 157.36. Shares in Caterpillar Inc (NYSE:CAT) rose to all time highs; up 3.17% or 15.41 to 502.12. Shares in NVIDIA Corporation (NASDAQ:NVDA) rose to all time highs; rising 2.18% or 4.04 to 189.08. Shares in Xenetic Biosciences Inc (NASDAQ:XBIO) rose to 3-years highs; up 146.08% or 6.15 to 10.36. Shares in Cenntro Electric Group Ltd (NASDAQ:CENN) fell to all time lows; losing 56.80% or 0.35 to 0.27.

          The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 5.45% to 16.30.

          Gold Futures for December delivery was up 1.48% or 59.17 to $4,063.57 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in November rose 1.05% or 0.65 to hit $62.38 a barrel, while the December Brent oil contract rose 1.01% or 0.66 to trade at $66.11 a barrel.

          EUR/USD was unchanged 0.24% to 1.16, while USD/JPY rose 0.49% to 152.71.

          The US Dollar Index Futures was up 0.31% at 98.59.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Nexalin Shares Soar After Neurostimulation Device Boosts Cognitive Performance for Alzheimer's Patients

          Dow Jones Newswires
          Nexalin Technology
          +1.86%
          Nexalin Technology, Inc. Warrant
          0.00%

          By Connor Hart

          Shares of Nexalin Technology nearly doubled after the company said its second-generation Sync neurostimulation device can improve cognitive performance and enhance brain network connectivity in patients with mild Alzheimer's disease.

          The stock jumped 91% to $1.79 in morning trading Wednesday. Despite the gain, shares have lost roughly one-third of their value so far this year.

          The company's statement is based on published data from a recent clinical trial, which showed that patients using Nexalin's device recorded significant improvements in cognitive assessments.

          Resting-state functional MRIs additionally revealed enhanced functional connectivity between the hippocampus and the key cortical regions that are critical to memory and executive function, Nexalin said.

          Nexalin's Sync neurostimulation device uses a specific electrical waveform to increase hippocampal-cortical connectivity. The device has already been approved in China to treat depression and insomnia, as well as in Brazil and Oman to treat anxiety, depression and insomnia, the company said.

          Nexalin said this new Alzheimer's data support its strategy to expand treatment indications. "The data clearly supports our belief that Nexalin's non-invasive deep, frequency-specific neurostimulation can meaningfully improve cognitive performance in patients with Alzheimer's disease," Chief Executive Mark White said.

          Write to Connor Hart at connor.hart@wsj.com

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share
          FastBull
          Copyright © 2025 FastBull Ltd

          728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG

          TelegramInstagramTwitterfacebooklinkedin
          App Store Google Play Google Play
          Products
          Charts

          Chats

          Q&A with Experts
          Screeners
          Economic Calendar
          Data
          Tools
          Membership
          Features
          Function
          Markets
          Copy Trading
          Latest Signals
          Contests
          News
          Analysis
          24/7
          Columns
          Education
          Company
          Careers
          About Us
          Contact Us
          Advertising
          Help Center
          Feedback
          User Agreement
          Privacy Policy
          Business

          White Label

          Data API

          Web Plug-ins

          Poster Maker

          Affiliate Program

          Risk Disclosure

          The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

          No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

          Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

          Not Logged In

          Log in to access more features

          FastBull Membership

          Not yet

          Purchase

          Become a signal provider
          Help Center
          Customer Service
          Dark Mode
          Price Up/Down Colors

          Log In

          Sign Up

          Position
          Layout
          Fullscreen
          Default to Chart
          The chart page opens by default when you visit fastbull.com